[HTML][HTML] Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)

M Inada, Y Nishimura, S Ishikura, K Ishikawa… - Radiation …, 2022 - Springer
Background JCOG1015A1 is an ancillary research study to determine the organ-specific
dose constraints in head and neck carcinoma treated with intensity-modulated radiation …

Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1).

M Inada, Y Nishimura, S Ishikura… - Radiation Oncology …, 2022 - europepmc.org
Background JCOG1015A1 is an ancillary research study to determine the organ-specific
dose constraints in head and neck carcinoma treated with intensity-modulated radiation …

[HTML][HTML] Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)

M Inada, Y Nishimura, S Ishikura… - Radiation …, 2022 - ro-journal.biomedcentral.com
JCOG1015A1 is an ancillary research study to determine the organ-specific dose constraints
in head and neck carcinoma treated with intensity-modulated radiation therapy (IMRT) using …

Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)

M Inada, Y Nishimura, S Ishikura… - Radiation …, 2022 - search.proquest.com
Background JCOG1015A1 is an ancillary research study to determine the organ-specific
dose constraints in head and neck carcinoma treated with intensity-modulated radiation …

Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)

M Inada, Y Nishimura, S Ishikura… - Radiation …, 2022 - u-toyama.elsevierpure.com
Background: JCOG1015A1 is an ancillary research study to determine the organ-specific
dose constraints in head and neck carcinoma treated with intensity-modulated radiation …

Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1).

M Inada, Y Nishimura, S Ishikura… - Radiation …, 2022 - search.ebscohost.com
Abstract < bold> Background: </bold> JCOG1015A1 is an ancillary research study
to determine the organ-specific dose constraints in head and neck carcinoma treated with …

[HTML][HTML] Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)

M Inada, Y Nishimura, S Ishikura… - Radiation Oncology …, 2022 - ncbi.nlm.nih.gov
Background JCOG1015A1 is an ancillary research study to determine the organ-specific
dose constraints in head and neck carcinoma treated with intensity-modulated radiation …

Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)

M Inada, Y Nishimura, S Ishikura… - Radiation …, 2022 - pubmed.ncbi.nlm.nih.gov
Background JCOG1015A1 is an ancillary research study to determine the organ-specific
dose constraints in head and neck carcinoma treated with intensity-modulated radiation …

Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)

M Inada, Y Nishimura, S Ishikura, K Ishikawa… - Radiation …, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
JCOG1015A1 is an ancillary research study to determine the organ-specific dose constraints …

[PDF][PDF] Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)

M Inada, Y Nishimura, S Ishikura, K Ishikawa… - 2022 - d-nb.info
Background: JCOG1015A1 is an ancillary research study to determine the organ-specific
dose constraints in head and neck carcinoma treated with intensity-modulated radiation …